Clinical trial NCT06843473: Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Study in India, Pakistan, Philippines and Vietnam
Official title: Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Cross-sectional Study in India, Pakistan, Philippines and Vietnam
Study type: OBSERVATIONAL
Overall status: ENROLLING_BY_INVITATION
Conditions: Obesity
Obesity-related Complications
Lead sponsor: Novo Nordisk A/S
Sponsor class: INDUSTRY
First posted: 2025-02-25
Enrollment: 1165
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Participants will be assessed for obesity-related complications, including measurement of Body Mass Index (BMI)

Brief summary: This study is investigating how common weight related health problems are in people of different weight categories in India, Pakistan, Philippines, and Vietnam. The purpose of the study is to understand the prevalence of weight related health problems in different weight groups. Participants will continue their normal care and will not get any treatment as part of this study; participants will continue receiving any treatments their doctor has prescribed. The study will last for about 2 years.


Eligibility criteria: Inclusion Criteria:

* Informed consent obtained before any study related activities (study-related activities are any procedure related to recording of data according to the protocol).
* Male or female aged 18 years or older at the time of signing informed consent.
* Presence of at least one Weight-related complication.

Exclusion Criteria:

* Participants less than 18 years of age at the time of signing informed consent.
* Pregnant women and individuals with recent weight loss due to illness, defined as more than 5 percent (%) weight loss in the past 6 months.

Primary outcomes:
measure: Proportion of Weight-Related Complications Across Different Body Mass Index (BMI) Classes
timeFrame: Upon data collection (Day 1)
Secondary outcomes:
Other outcomes:
Locations:
city: New Delhi
country: India
facility: AIIMS,Delhi
state: Delhi
city: Bangalore
country: India
facility: Bangalore Diabetes Centre
state: Karnataka
city: Belgaum
country: India
facility: Belgaum Diabetes Centre
state: Karnataka
city: Mumbai
country: India
facility: KGN Diabetes and Endocrinology Centre
state: Maharashtra
city: Ansari Nagar
country: India
facility: All India Institute of Medical Sciences_Delhi
state: New Delhi
city: Bhubaneswar
country: India
facility: Endeavour Clinic - Centre of Diabetes and Endocrinology, Bhubaneswar.
state: Odisha
city: Kolkata
country: India
facility: IPGME&R and SSKM Hospital
state: West Bengal
city: Karachi
country: Pakistan
facility: Aga Khan University Hospital
city: Lahore
country: Pakistan
facility: National Hospital Lahore
city: Metro Manila
country: Philippines
facility: Asian Hospital and Medical Center
state: San Juan
city: Ho Chi Minh
country: Vietnam
facility: Tam Anh TP. Ho Chi Minh General Hospital
state: Tan Binh
Study officials:
affiliation: Novo Nordisk A/S
name: Clinical Transparency (dept. 2834)
role: STUDY_DIRECTOR
References: